Cargando…
Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor. Although IMT generally exhibits benign biological behavior, some IMT patients may develop local recurrence or even distant metastasis. Surgery is the most common therapeutic approach. However, additional treatment options are nece...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797413/ https://www.ncbi.nlm.nih.gov/pubmed/35116315 http://dx.doi.org/10.21037/tcr-21-1885 |
_version_ | 1784641546808721408 |
---|---|
author | Zhang, Yizhong Zheng, Guoping Meng, Xiaopeng Li, Yuanjing Shi, Dan Yu, Jinna |
author_facet | Zhang, Yizhong Zheng, Guoping Meng, Xiaopeng Li, Yuanjing Shi, Dan Yu, Jinna |
author_sort | Zhang, Yizhong |
collection | PubMed |
description | Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor. Although IMT generally exhibits benign biological behavior, some IMT patients may develop local recurrence or even distant metastasis. Surgery is the most common therapeutic approach. However, additional treatment options are necessary for those who are unable to undergo surgical treatments. Microwave ablation (MWA) is a developing treatment option for unresectable lung cancer. Compared with radiofrequency ablation (RFA), MWA possesses many advantages including larger ablation zones, shorter heating times, and less susceptibility to heat sink. Herein, we reported the case of an 80-year-old male patient who presented with a mass in the right lower pulmonary lobe and right pleural effusion. The maximum diameter of the mass was 53.76 mm, and the patient’s main complaint was fatigue for 2 months. Blood test showed severe anemia (hemoglobin: 79 g/L) and hypoproteinemia (albumin: 27.7 g/L). After undergoing blood transfusion, supplementation of albumin, thoracical puncturing and piping, the patient’s nutritional condition was improved (hemoglobin, 95 g/L; serum albumin, 29.9 g/L). The pathological diagnosis was pulmonary IMT by percutaneous lung biopsy. The patient was successfully treated with three rounds of percutaneous MWA and has no evidence of recurrence nearly 3 years later. This case has expanded the therapeutic options for elderly patients with pulmonary IMT. Percutaneous MWA monotherapy might serve as an emerging treatment strategy for medically inoperable patients. |
format | Online Article Text |
id | pubmed-8797413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87974132022-02-02 Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review Zhang, Yizhong Zheng, Guoping Meng, Xiaopeng Li, Yuanjing Shi, Dan Yu, Jinna Transl Cancer Res Case Report Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor. Although IMT generally exhibits benign biological behavior, some IMT patients may develop local recurrence or even distant metastasis. Surgery is the most common therapeutic approach. However, additional treatment options are necessary for those who are unable to undergo surgical treatments. Microwave ablation (MWA) is a developing treatment option for unresectable lung cancer. Compared with radiofrequency ablation (RFA), MWA possesses many advantages including larger ablation zones, shorter heating times, and less susceptibility to heat sink. Herein, we reported the case of an 80-year-old male patient who presented with a mass in the right lower pulmonary lobe and right pleural effusion. The maximum diameter of the mass was 53.76 mm, and the patient’s main complaint was fatigue for 2 months. Blood test showed severe anemia (hemoglobin: 79 g/L) and hypoproteinemia (albumin: 27.7 g/L). After undergoing blood transfusion, supplementation of albumin, thoracical puncturing and piping, the patient’s nutritional condition was improved (hemoglobin, 95 g/L; serum albumin, 29.9 g/L). The pathological diagnosis was pulmonary IMT by percutaneous lung biopsy. The patient was successfully treated with three rounds of percutaneous MWA and has no evidence of recurrence nearly 3 years later. This case has expanded the therapeutic options for elderly patients with pulmonary IMT. Percutaneous MWA monotherapy might serve as an emerging treatment strategy for medically inoperable patients. AME Publishing Company 2021-10 /pmc/articles/PMC8797413/ /pubmed/35116315 http://dx.doi.org/10.21037/tcr-21-1885 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Zhang, Yizhong Zheng, Guoping Meng, Xiaopeng Li, Yuanjing Shi, Dan Yu, Jinna Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
title | Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
title_full | Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
title_fullStr | Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
title_full_unstemmed | Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
title_short | Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
title_sort | microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797413/ https://www.ncbi.nlm.nih.gov/pubmed/35116315 http://dx.doi.org/10.21037/tcr-21-1885 |
work_keys_str_mv | AT zhangyizhong microwaveablationforthemanagementofpulmonaryinflammatorymyofibroblastictumoracasereportandliteraturereview AT zhengguoping microwaveablationforthemanagementofpulmonaryinflammatorymyofibroblastictumoracasereportandliteraturereview AT mengxiaopeng microwaveablationforthemanagementofpulmonaryinflammatorymyofibroblastictumoracasereportandliteraturereview AT liyuanjing microwaveablationforthemanagementofpulmonaryinflammatorymyofibroblastictumoracasereportandliteraturereview AT shidan microwaveablationforthemanagementofpulmonaryinflammatorymyofibroblastictumoracasereportandliteraturereview AT yujinna microwaveablationforthemanagementofpulmonaryinflammatorymyofibroblastictumoracasereportandliteraturereview |